3654 results for «209»

Filter By

3654 results

PCR's Got Talent - Round 2 - Session 1

15 May 2024 – From EuroPCR 2024

PCR's Got Talent - Round 2 - Session 1

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

PCR's Got Talent - Round 2 - Session 2

15 May 2024 – From EuroPCR 2024

This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).

PCR's Got Talent - Round 2 - Session 2

TEER for primary mitral regurgitation - LIVE case

15 May 2024 – From EuroPCR 2024

A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...

Mitral TEER

Valve-in-valve: utility of splitting devices

15 May 2024 – From EuroPCR 2024

This session focuses on the use of specialized splitting devices for transcatheter aortic valve-in-valve procedures. It features a case series demonstrating the application of a dedicated splitting device in failed TAVI valves, as well as the use of the BASILICA technique for transcatheter aortic valve replacement....

Valve-in-valve: utility of splitting devices

Devices in pulmonary embolism - Why you should be interested!

15 May 2024 – From EuroPCR 2024

This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...

Devices in pulmonary embolism - Why you should be interested!

Management of patient with coronary artery disease and left ventricle dysfunction

15 May 2024 – From EuroPCR 2024

This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...

Management of patient with coronary artery disease and left ventricle dysfunction

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance at 5 Years

19 Nov 2025

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

04 Nov 2024

Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.

Also watch the interview with Susheel K. Kodali

Alessandro Sticchi

Author

Alessandro Sticchi
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

HOST-EXAM:10-year follow-up of clopidogrel vs aspirin monotherapy in stable CAD after PCI with drug-eluting stent

30 Mar 2026

Nicola Ryan provides her take on the 10-year follow-up of the HOST-EXAM, which was presented by Hyo-Soo Kim at ACC.26 in New Orleans.

Nicola Ryan

Author

Nicola Ryan
10-year follow-up of clopidogrel vs aspirin monotherapy in stable coronary artery disease after percutaneous coronary intervention with drug-eluting stent
Didn’t find what you were looking for?